FORGHIERI, Fabio
 Distribuzione geografica
Continente #
NA - Nord America 10.631
EU - Europa 4.669
AS - Asia 4.244
SA - Sud America 551
AF - Africa 95
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 9
Totale 20.216
Nazione #
US - Stati Uniti d'America 10.476
GB - Regno Unito 1.400
SG - Singapore 1.277
CN - Cina 1.078
IT - Italia 787
SE - Svezia 596
HK - Hong Kong 579
VN - Vietnam 520
DE - Germania 415
FI - Finlandia 407
BR - Brasile 403
RU - Federazione Russa 236
FR - Francia 220
UA - Ucraina 186
IN - India 140
TR - Turchia 138
KR - Corea 96
BG - Bulgaria 71
CA - Canada 66
ID - Indonesia 66
JP - Giappone 64
BD - Bangladesh 56
NL - Olanda 55
AR - Argentina 49
BE - Belgio 44
MX - Messico 42
IQ - Iraq 40
CZ - Repubblica Ceca 38
ES - Italia 34
IE - Irlanda 27
PL - Polonia 25
LT - Lituania 23
ZA - Sudafrica 23
EC - Ecuador 22
AE - Emirati Arabi Uniti 21
CO - Colombia 19
IR - Iran 19
AT - Austria 16
CL - Cile 16
MA - Marocco 16
PK - Pakistan 16
PY - Paraguay 15
UZ - Uzbekistan 15
AZ - Azerbaigian 14
BZ - Belize 13
EG - Egitto 13
JO - Giordania 13
CH - Svizzera 12
EU - Europa 12
VE - Venezuela 12
DK - Danimarca 11
KE - Kenya 11
PH - Filippine 11
SA - Arabia Saudita 10
SK - Slovacchia (Repubblica Slovacca) 10
MY - Malesia 9
AU - Australia 8
IL - Israele 8
JM - Giamaica 8
RO - Romania 8
TN - Tunisia 8
PT - Portogallo 7
TW - Taiwan 7
CR - Costa Rica 6
DZ - Algeria 6
UY - Uruguay 6
AL - Albania 5
CY - Cipro 5
ET - Etiopia 5
GR - Grecia 5
LB - Libano 5
NO - Norvegia 5
NP - Nepal 5
PE - Perù 5
PS - Palestinian Territory 5
RS - Serbia 5
GT - Guatemala 4
OM - Oman 4
PA - Panama 4
BH - Bahrain 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
EE - Estonia 3
KG - Kirghizistan 3
MD - Moldavia 3
MK - Macedonia 3
NI - Nicaragua 3
QA - Qatar 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
HU - Ungheria 2
KZ - Kazakistan 2
LV - Lettonia 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
Totale 20.190
Città #
Fairfield 1.188
Ashburn 1.165
Southend 978
Santa Clara 852
Singapore 821
Woodbridge 746
Chandler 591
Hong Kong 568
Houston 562
Ann Arbor 455
Seattle 451
San Jose 407
Cambridge 357
Wilmington 337
Nyköping 331
Jacksonville 328
Dearborn 317
Helsinki 314
Hefei 251
Beijing 214
Modena 213
London 193
New York 173
Ho Chi Minh City 167
Los Angeles 133
Hanoi 116
Munich 98
The Dalles 95
Chicago 89
Council Bluffs 89
Seoul 81
San Diego 80
Fremont 73
Sofia 70
Bremen 67
Milan 67
Princeton 66
Lauterbourg 65
Izmir 64
Eugene 63
Moscow 56
Bologna 53
Shanghai 53
Buffalo 47
Dallas 46
Jakarta 43
Orem 38
São Paulo 38
Redwood City 34
Frankfurt am Main 33
Brussels 32
Tokyo 31
Boardman 30
Da Nang 28
Salt Lake City 28
Turku 28
Atlanta 27
Chennai 27
Columbus 27
Brooklyn 26
Dublin 25
Des Moines 24
Montreal 24
Rome 23
Toronto 21
Guangzhou 18
Denver 17
Las Vegas 17
Paris 17
Stockholm 17
Dong Ket 16
Warsaw 16
Baghdad 15
Haiphong 15
Phoenix 15
Mexico City 14
Mumbai 14
Tashkent 14
Albuquerque 13
Belize City 13
Kunming 13
Rio de Janeiro 13
San Francisco 13
Washington 13
Boston 12
Brno 12
Deventer 12
Johannesburg 12
Quito 12
Hải Dương 11
Nairobi 11
Tampa 11
Wuhan 11
Amsterdam 10
Leawood 10
Manchester 10
Miano 10
Nanjing 10
Amman 9
Asunción 9
Totale 14.592
Nome #
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 438
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 418
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 399
B cells and herpesviruses: a model of lymphoproliferation 397
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 391
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 390
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 367
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 360
Acute appendicitis in adult neutropenic patients with hematologic malignancies 354
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 352
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 349
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 348
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 342
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 341
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 332
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 331
Mucorales-specific T cells in patients with hematologic malignancies 326
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 323
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 318
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 318
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 317
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 309
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 307
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 304
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 302
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 302
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 301
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 296
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 292
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 290
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 285
Inflammatory myofibroblastic tumor of the bone marrow. 283
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 282
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 281
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 277
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 277
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 276
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 273
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 271
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 269
Pain and emotional distress in leukemia patients at diagnosis. 264
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 263
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 261
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 260
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 259
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 259
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 258
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 257
Safety profile of Erwinia asparaginase treatment in adults with newly diagnosed acute lymphoblastic leukemia: a retrospective monocenter study 253
Variability of Voriconazole Trough Levels in Haematological Patients: Influence of Comedications with cytochrome P450(CYP) Inhibitors and/or with CYP Inhibitors plus CYP Inducers 249
Splenic hyalohyphomycosis, molecularly and immunologically consistent with invasive aspergillosis, in a patient with acute lymphoblastic leukemia. 248
How I treat HHV8/KSHV-related diseases in posttransplant patients. 248
Tumor-targeted immunoliposomal nanosystems to deliver either Cidofovir or Antineoplastic SiRNA against Primary Effusion Lymphoma (PEL) 242
Splenomegaly in hematological malignancies and portal hypertension 237
Acute promyelocytic leukemia in very elderly patients: still aclinical challenge. 233
Minimal/Measurable Residual Disease Monitoring in NPM1-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives 222
Interferon-alpha may restore sensitivity to tyrosine-kinase inhibitors in Philadelphia chromosome positive acute lymphoblastic leukaemia with F317L mutation 221
Philadelphia chromosome-positive acute lymphoblastic leukemia 220
Early palliative/supportive care in acute myeloid leukaemia allows low aggression end-of-life interventions: Observational outpatient study 216
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 214
Pain and emozional distress in hematological patients throughout all phases of disease: results from a multidisciplinary research team in Modena University Hospital 208
Multicenter retrospective analysis of clinical outcome of adult patients with mixed-phenotype acute leukemia treated with acute myeloid leukemia-like or acute lymphoblastic leukemia-like chemotherapy and impact of allogeneic stem cell transplantation: a Campus ALL study 204
Ibrutinib Is a Newly Recognized Host Factor for the Definition of Probable Invasive Pulmonary Mold Disease, Based on Off-target Effects, Unrelated to Its B-cell Immunosuppressant Activity 202
May the correlation between Kit-D816 mutation and AML1-ETO level change the use of prognostic factors in t(8;21) AML? 199
Severe pneumonia caused by Legionella pneumophila serogroup 11, Italy. 198
Persistent hiccups as an adverse event to FLAG-IDA regimenfor leukemia. 197
β-HHVs and HHV-8 in Lymphoproliferative Disorders. 183
Edmonton symptom assessment system Global Distress Score and overall survival in acute leukaemia 163
Improved efficacy of quizartinib in combination therapy with PI3K inhibition in primary FLT3-ITD AML cells 147
Preclinical Validation of an Advanced Therapy Medicinal Product Based on Cytotoxic T Lymphocytes Specific for Mutated Nucleophosmin (NPM1mut) for the Treatment of NPM1mut-Acute Myeloid Leukemia 144
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience 141
Identification and validation of diagnostic cut-offs of the ELISpot assay for the diagnosis of invasive aspergillosis in high-risk patients 136
The dynamic functions of IRF4 in B cell malignancies 99
OPTICAL GENOME MAPPING IDENTIFIES MULTIPLE STRUCTURAL VARIATION AND CATASTROPHIC REARRANGEMENTS IN B-CELL PROLYMPHOCYTIC LEUKEMIA 2
Optical genome mapping reveals multiple apoptotic and cell-cycle pathway aberrations in B-cell prolymphocytic leukemia: a report of three cases 2
CLINICAL OUTCOMES OF YOUNGER ADULT PATIENTS WITH PHILADELPHIANEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA, TREATED IN THE REAL-LIFE WITH A PEDIATRIC-LIKE REGIMEN BASED ON GIMEMA LAL1308 PROTOCOL: AN OBSERVATIONAL RETROSPECTIVE CAMPUS ALL STUDY 1
Hemopoietic stem cell transplantation for infectious mononucleosis-related aplastic anemia 1
Quality of life and symptoms in acute myeloid leukaemia with early palliative care: real-world observational study 1
Totale 20.440
Categoria #
all - tutte 72.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.894


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021280 0 0 0 0 0 0 0 0 0 0 141 139
2021/20221.553 69 208 160 96 32 71 85 83 140 145 296 168
2022/20231.765 231 219 109 173 273 203 58 169 163 23 72 72
2023/20241.191 33 48 92 88 215 139 137 210 23 22 77 107
2024/20253.149 129 44 72 214 567 464 237 175 397 96 284 470
2025/20265.589 480 241 414 572 884 466 888 331 667 541 105 0
Totale 20.440